Association of AEBP1 and NRN1 RNA expression with Alzheimer’s disease and neurofibrillary tangle density in middle temporal gyrus

[1]  Satoshi O. Suzuki,et al.  Association of adipocyte enhancer‐binding protein 1 with Alzheimer's disease pathology in human hippocampi , 2018, Brain pathology.

[2]  R. Faull,et al.  Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease , 2017, International journal of molecular sciences.

[3]  Junwei Han,et al.  LncRNAs2Pathways: Identifying the pathways influenced by a set of lncRNAs of interest based on a global network propagation method , 2017, Scientific Reports.

[4]  M. Hoshino.  Fibril formation from the amyloid-β peptide is governed by a dynamic equilibrium involving association and dissociation of the monomer , 2016, Biophysical Reviews.

[5]  James A. Eddy,et al.  Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases , 2016, Scientific Data.

[6]  Yinghui Chen,et al.  Long noncoding RNAs and Alzheimer’s disease , 2016, Clinical interventions in aging.

[7]  Måns Magnusson,et al.  MultiQC: summarize analysis results for multiple tools and samples in a single report , 2016, Bioinform..

[8]  Alzheimer’s Association,et al.  2016 Alzheimer's disease facts and figures , 2016, Alzheimer's & Dementia.

[9]  J. Enghild,et al.  New Insights to Clathrin and Adaptor Protein 2 for the Design and Development of Therapeutic Strategies , 2015, International journal of molecular sciences.

[10]  Fei Li,et al.  MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin , 2015, Brain Research.

[11]  J. Hirschhorn,et al.  Small island, big genetic discoveries , 2015, Nature Genetics.

[12]  M. Faghihi,et al.  Transcriptomics Profiling of Alzheimer’s Disease Reveal Neurovascular Defects, Altered Amyloid-β Homeostasis, and Deregulated Expression of Long Noncoding RNAs , 2015, Journal of Alzheimer's disease : JAD.

[13]  H. Shill,et al.  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program , 2015, Neuropathology : official journal of the Japanese Society of Neuropathology.

[14]  I. Lombardo,et al.  The efficacy of RVT-101, a 5-ht6 receptor antagonist, as an adjunct to donepezil in adults with mild-to-moderate Alzheimer’s disease: Completer analysis of a phase 2b study , 2015, Alzheimer's & Dementia.

[15]  D. Ulrich.  Amyloid-β Impairs Synaptic Inhibition via GABAA Receptor Endocytosis , 2015, The Journal of Neuroscience.

[16]  Fei Gao,et al.  Decreased γ‐aminobutyric acid levels in the parietal region of patients with Alzheimer's disease , 2015, Journal of magnetic resonance imaging : JMRI.

[17]  R. Quirion,et al.  Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer's disease , 2015, Front. Aging Neurosci..

[18]  Alzheimer’s Association.  2015 Alzheimer's disease facts and figures , 2015, Alzheimer's & Dementia.

[19]  Ahmet Kurdoglu,et al.  Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes , 2015, Neurobiology of Aging.

[20]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[21]  H. J. Kim,et al.  Neuritin can normalize neural deficits of Alzheimer's disease , 2014, Cell Death and Disease.

[22]  S. Hahn,et al.  Neuritin Attenuates Cognitive Function Impairments in Tg2576 Mouse Model of Alzheimer's Disease , 2014, PloS one.

[23]  A. Bittner,et al.  Comparison of RNA-Seq and Microarray in Transcriptome Profiling of Activated T Cells , 2014, PloS one.

[24]  Chadwick M. Hales,et al.  U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease , 2013, Proceedings of the National Academy of Sciences.

[25]  A. Hill,et al.  Intracellular Itinerary of Internalised β‐Secretase, BACE1, and Its Potential Impact on β‐Amyloid Peptide Biogenesis , 2013, Traffic.

[26]  Carl W. Cotman,et al.  Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease , 2013, Neurobiology of Aging.

[27]  Tomio Sasaki,et al.  Altered Expression of Diabetes-Related Genes in Alzheimer's Disease Brains: The Hisayama Study , 2013, Cerebral cortex.

[28]  J. D. Mills,et al.  RNA-Seq analysis of the parietal cortex in Alzheimer's disease reveals alternatively spliced isoforms related to lipid metabolism , 2013, Neuroscience Letters.

[29]  J. Schneider,et al.  Overview and findings from the religious orders study. , 2012, Current Alzheimer research.

[30]  M. Faust.  The Handbook of the Neuropsychology of Language: Faust/The Handbook of the Neuropsychology of Language , 2012 .

[31]  M. Wilkins,et al.  Whole Transcriptome Sequencing Reveals Gene Expression and Splicing Differences in Brain Regions Affected by Alzheimer's Disease , 2011, PloS one.

[32]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[33]  E. Birney,et al.  Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt , 2009, Nature Protocols.

[34]  Eric M Reiman,et al.  Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. , 2008, Physiological genomics.

[35]  Winnie S. Liang,et al.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.

[36]  Eric M Reiman,et al.  Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. , 2007, Physiological genomics.

[37]  S. Royle,et al.  The cellular functions of clathrin , 2006, Cellular and Molecular Life Sciences CMLS.

[38]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Grady,et al.  Neuronal and glial cell number in the hippocampus after experimental traumatic brain injury: analysis by stereological estimation. , 2003, Journal of neurotrauma.

[40]  R. Cabeza,et al.  Neural bases of learning and memory: functional neuroimaging evidence , 2000, Current opinion in neurology.

[41]  A. Convit,et al.  Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[42]  M. Ramakrishnan,et al.  Neuritin: a gene induced by neural activity and neurotrophins that promotes neuritogenesis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Huentelman,et al.  Transcriptome Changes in the Alzheimer's Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes. , 2019, Journal of Alzheimer's disease : JAD.

[44]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[45]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .